GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human transthyretin complexed with glabridin

Analyse Crystal structure of human transthyretin complexed with glabridin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4N86
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
GBJ, CA
Pockets
3 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1155% helix, 51% strandP02766

Ligands and binding sites

  • GBJ · 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H,8H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1910.380.7618empty
2650.340.7716empty
3640.260.7218empty

Interfaces

1 interface between chains.

  • A–B · 902 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 4N86 · Crystal structure of human transthyretin complexed with glabridin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.